FEBS LettersSystems BiologyPeer-reviewed journal article
Why do pathway methods work better than they should?
Abstract
Different pathway analysis methods are frequently applied to cancer gene expression data to identify dysregulated pathways. In most cases these methods infer pathway activity changes based on the gene expression of pathway members. However, pathways are constituted by signaling proteins, and their activity - not their abundance - defines the activity of the pathway; the association between gene expression and protein activity is in turn limited and not well characterised. Other methods infer pathway activity from the expression of the genes whose transcription is regulated by the pathway of interest, which seems a more adequate proxy of activity. Despite these potential limitations, membership based pathway methods are frequently used and often provide statistically significant results. Here, we submit that pathway based methods are not effective because of the correlation between the gene expression of pathway members and the activity of the pathway, but because pathway member gene sets overlap with the genes regulated by transcription factors (regulons). This implies that pathway methods do not inform about the activity of the pathway of interest, but instead the downstream effects of changes in the activities of transcription factors. To support our hypothesis, we show that the higher the overlap to transcription factor regulons, the higher the information value of pathway gene sets. Furthermore, removing these overlapping genes reduces the information content of pathway gene sets, but not vice versa. Our results suggest that results of classical pathway analysis methods should be interpreted with caution, and instead methods using pathway regulated genes for activity inference should be prioritised. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=129 SRC="FIGDIR/small/228296v1_ufig1.gif" ALT="Figure 1"> View larger version (25K): org.highwire.dtl.DTLVardef@f955baorg.highwire.dtl.DTLVardef@16b2f0aorg.highwire.dtl.DTLVardef@1dd6b7dorg.highwire.dtl.DTLVardef@1bbfe59_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: benchmarking
- approach: statistical model
- Citations
- 34
- FWCI
- 1.62
- Field percentile
- top 16%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Perturbation-response genes reveal signaling footprints in cancer gene expression
Michael Schubert, Bertram Klinger, … Julio Saez-Rodriguez·bioRxiv·Aug 28, 2016
- Expanding the coverage of regulons from high-confidence prior knowledge for accurate estimation of transcription factor activities
Sophia Müller‐Dott, Eirini Tsirvouli, … Julio Sáez-Rodríguez·Nucleic Acids ResearchPeer-reviewed·Sep 22, 2023
- Coherent pathway enrichment estimation by modeling inter-pathway dependencies using regularized regression
Kim Philipp Jablonski, Niko Beerenwinkel·BioinformaticsPeer-reviewed·Aug 1, 2023
- Prius: From Differentiated Genes to Affected Pathways
Shailesh Patil, Bharath Venkatesh, Randeep Singh·bioRxiv·Jun 8, 2016
- Can we assume the gene expression profile as a proxy for signaling network activity?
Mehran Piran, Reza Karbalaei, … Mohieddin Jafari·BiomoleculesPeer-reviewed·Jun 3, 2020
- Predicting transcription factor activity using prior biological information
Joseph Estabrook, William M. Yashar, … Emek Demir·bioRxiv·Dec 16, 2022